Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ex date was 4 years ago this year.
Any updates? Paul the plumber is there any update with accustem? Aren’t you doing PR there now?
No updates since what last June or something ?
So they moved from AIM to the Nasdaq and it just keeps tanking despite all the news updates.
7th June 2023 was the interview with proactive investors, over 8 months now and no update on commercialisation or the university hospital collab outcome.
Sick of this.
Someone on stocktwits is feeling the same as me RE accustem. How are they still functioning with no cash
Where’s the PR GUY? It’s 10% of the way through 2024 now and no accustem updates
'At last after 28 months'
Bl**dy traders ruining this share!
At last after 28 months. I was just preparing to provide the Ombudsman with documents from my complaint !!
My Barclays account is quoting TILS in USA dollars and showing them as sellable this morning!
Is the plumber/PR guy still ramping on these boards ?
Is there an update on accustem ?
Is Tiziana staying on Nasdaq ?
What happened to the accustem university hospital data sets?
How are accustem funding operations.
WHAT IS HAPPENING?
1133 days since the accustem ex date,
4 years this year and no uplisting. I know biotech has been in a bear market but why not update regular long term holders ?
It just stinks.
No updates on accustem.
What a load of old cobblers. Into our 4th year now
?
I have watched the Blosser interview about 5 times, they were going to present their results at the san Antonio breast cancer conference in December, but I didn’t see anything about that.
It’s almost end of Jan now and no update.
No. Just an acknowledgement of complaint.
Barclays said they understand my frustration but they have not mishandled the situation!! Yet how come after 2years 3 months are they in physical and legal challenges?...which I hasten to add they have given no explanation at all.
Highly likely a cover up in the hope of being able to trade on the Nasdaq capital market at some point. They just ignored this at the time. At the very least they should have informed their investors of the situation before delisting so an informed decision could have been made as to whether to sell.
I agree
2seabass
I sent them another email Friday for an update as what you say is exactly what they have said. So at least we know what there failings are, suggested another Post Office fiasco to them and that I will be seeking the assistance of the ombudsman if not solved.
Also stated that if the price moves to $6 ( we live in hope ) i will be sending them a sale request and if they are unable to trade then I will be looking to them for the value....
I guess they'll just suggest the ombudsman, have you had any luck with the ombudsman yet ?
Sturam007
I suggest you get in touch with Ombudsman.
Barclays informed me that they were going to create a trading platform for Nasdaq. It did eventually come live but a long time after they had hoped and way after the corporate action to de list and on to Nasdaq.
I strongly believe that they were hoping to trade our shares once it got up and running. However through lack of due diligence they failed because Tils is in fact on the capital market within the Nasdaq which is not incorporated in their platform. In my mind therefore the window of opportunity to provide a way of transferring our shares to another broker such as HL was lost. My complaints investigation got passed from pillar to post before they discovered this readily available information....now its physical and legal challenges they face to sort it out whilst we our denied any tenure whilst watching our investment going down the DRAIN!!
Compensation must be secured.
Transferred account from BSI to AJB prior to NASDAQ so do hold and can trade TLSA. However, if you are a long term holder of TLSA you will be entitled to Accustem shares which were spun out of TILS. When (if) ACUT eventually float on NASDAQ then you and I will face similar problems in trying to get Barclays to give us our shares.
Yes with Barclays too and same as you 2SEABASS, its a complete joke, and they just blame the other parties, very little we can do but wait. I'm in contact with them but haven't taken it to the ombudsman yet, lucky no reason to sell over the last couple of years !
You’ve got to be having a laugh? Over 2 years to get your entitlements?
I hold quite a few TILS & Accustem and can’t wait for a resolution whether it be months or years so I can sell and never revisit this again. I’ve been in for 3, 4 or 5 years now. Sick of it. To see the story change weekly just makes me laugh now. I suppose I’m relying on other gullible future investors to get me out of jail. Sad, but at least I’m honest
I've just notified the ombudsman that Barclay's still haven't sorted out the corporate action in Oct 2021 to list my shares on Nasdaq. Barclays have not upheld my complaint due to "physical and legal challenges "
Tiziana investor relations told me that many others made complaints regarding this unacceptable position with Barclays and went on to inform me that some have sought help from the ombudsman
IS THERE ANYONE ELSE OUT THERE IN THE SAME POSITION AS MYSELF?
Again watch the proactive video about accustem
It’s been what 6 months now since the last update?
Are they alive? Do they have any funding?
It’s been over 1000 days I think since the demerger.
Anything happening at all whatsoever?..
I like that bit at the end the company maybe aloud an additional 180 days plenty of time yet for it to come good. I for one think it will there isn't a pile of news coming out but what there is seems to be good
New York, July 21, 2023 – Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today disclosed the receipt of a notice (the “Notice”) on July 19, 2023 from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not currently in compliance with the $1.00 Minimum Bid Price Requirement for continued listing of the Company’s common shares on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The
Notice indicated that, consistent with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 days, or until January 16, 2024 (the “Compliance Deadline”), to regain compliance with the Minimum Bid Price Requirement by having the closing bid price of the Company’s ordinary share’s meet or exceed $1.00 per ordinary share for at least ten consecutive business days.
The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. Tiziana intends to monitor the closing bid price of its common shares and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement. If the Company does not regain compliance by the Compliance Deadline, the
Company may be afforded an additional 180 calendar day period to regain compliance.
The Company intends to resolve the deficiency and regain compliance with the Listing Rules.
GLA
BB
Tomorrow night D. DAY unless we get an extension 🤞